Merhaba!

Kurumsal Kimliğimiz yenilendi.
Yeni web sitemize hoş geldiniz.

Sağlık yolculuğunuz
artık daha kolay.

Sizi daha iyi bilgilendirmek ve
sağlık hizmetlerimize daha hızlı
ulaşmanızı sağlamak için yanınızdayız.


Çakırtepe Hastanesi
Corporate

CA 19-9 Test

General Information About the Test

CA 19-9 (Carbohydrate Antigen 19-9) is a tumor marker produced particularly by the cells of the pancreas, gallbladder, and biliary tract. Measuring the level of this protein in the blood is frequently requested by Medical Oncology and Gastroenterology specialists to help diagnose pancreatic cancer and biliary tract cancers, determine the stage of the disease, and monitor success during the treatment process.

Test Process and Preparation

CA 19-9 test and pancreatic/biliary tract evaluations.
Is CA 19-9 sufficient for the diagnosis of pancreatic cancer?

It is not sufficient to establish a definitive diagnosis on its own. It is mandatory to evaluate it in conjunction with advanced imaging and pathological methods such as Computed Tomography (CT), MRI, or biopsy.

Can it also rise in benign diseases?

Yes. The CA 19-9 value can reach very high levels in non-cancerous conditions as well, such as gallstones, biliary tract obstructions, pancreatitis (inflammation of the pancreas), and certain liver diseases.

Is fasting required before the test?

Fasting is not strictly required solely for the CA 19-9 test. However, since it is typically requested along with other biochemical blood tests indicating biliary tract and liver functions, an 8-10 hour fast is generally preferred.

The information on this page is for informational purposes only. The results of medical tests must be evaluated by specialist physicians.


You can find all the information regarding your treatment and hospital stay process in this section.

Patient Visits

Patient Visits

Details
Surgeries

Surgeries

Details
Patient Admission

Patient Admission

Details
Maternity Services

Maternity Services

Details
E-Appointment
E-Consultation
Contact Us